Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Controversies in platelet transfusion therapy.

× No keyword cloud information.

19 in total

1. In vitro assessment of platelet storage lesion in leucoreduced random donor platelet concentrates.

Authors: Amal S Ahmed; Ola Leheta; Soha Younes
Journal: Blood Transfus Date: 2010-01 Impact factor: 3.443

2. A therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation.

Authors: Lise J Estcourt; Gemma L Crighton; Erica M Wood; Simon Stanworth; Marialena Trivella; Carolyn Doree; Alan Tinmouth; Michael F Murphy
Journal: Cochrane Database Syst Rev Date: 2014

3. Alternative agents versus prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation.

Authors: Lise J Estcourt; Richard Gregg; Simon Stanworth; Carolyn Doree; Marialena Trivella; Michael F Murphy; Alan Tinmouth
Journal: Cochrane Database Syst Rev Date: 2014

4. Comparison of different platelet count thresholds to guide administration of prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation.

Authors: Lise J Estcourt; Simon Stanworth; Carolyn Doree; Marialena Trivella; Sally Hopewell; Michael F Murphy; Alan Tinmouth
Journal: Cochrane Database Syst Rev Date: 2014

5. Different doses of prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation.

Authors: Lise J Estcourt; Simon Stanworth; Carolyn Doree; Marialena Trivella; Sally Hopewell; Michael F Murphy; Alan Tinmouth
Journal: Cochrane Database Syst Rev Date: 2014

6. Persistence of lymphocytotoxic antibodies in patients in the trial to reduce alloimmunization to platelets: implications for using modified blood products.

Authors: Sherrill J Slichter; Douglas Bolgiano; Kuo-Jang Kao; Thomas S Kickler; Janice McFarland; Jeffrey McCullough; Robert Woodson
Journal: Transfus Med Rev Date: 2011-02-23

Controversies in platelet transfusion therapy.

1. In vitro assessment of platelet storage lesion in leucoreduced random donor platelet concentrates.

2. A therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation.

3. Alternative agents versus prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation.

4. Comparison of different platelet count thresholds to guide administration of prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation.

5. Different doses of prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation.

6. Persistence of lymphocytotoxic antibodies in patients in the trial to reduce alloimmunization to platelets: implications for using modified blood products.

Review 7. The use of blood components in patients with malignancy.

Review 8. Towards increasing shelf life and haemostatic potency of stored platelet concentrates.

9. Use of platelet concentrate in eastern Ontario.

Review 10. [Alloimmunization and transfusion refractoriness to thrombocyte substitution].